Ethical Compliance
BIOCON
Sector:
Healthcare
Industry:
Biotechnology
Market Cap Class:
large
Revenue
2.1%
Debt
28.1%
Liquidity
4%
Revenue
Debt
Liquidity
2.1%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Other Income | ₹534.10 |
| Generics | ₹2,500.10 |
| Biosimilars | ₹8,818.30 |
| Research | ₹3,437.30 |
Questionable
INR Crores
Non Compliant
INR Crores
| Interest Income | ₹331.40 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹331.40 |
| Total: | ₹331.40 |
| Total Revenue: | ₹15,621.20 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹331.40
₹15,621.20
= 2.1%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
